Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 2025Biological and Clinical Sciences Research Journal

Comparative Side Effects of Carbetocin vs Oxytocin in Prevention of Postpartum Bleeding Following Cesarean Sections

View Full Paper
Ask AI
Bookmark
Share

Authors

ATAyesha Uzaima TarinMRMaria RasheedSAS E Amin

Discussion

Loading...

Member takes

Overview

Prospective study compares side effects and hemodynamic outcomes of carbetocin versus oxytocin for postpartum hemorrhage prevention in cesarean sections.

Key Points

  • Carbetocin and oxytocin showed comparable side effects, with 22% and 21% respectively.
  • Nausea was more common in the oxytocin group at 14% compared to 8% for carbetocin.
  • Both agents had similar hemodynamic outcomes, evidenced by mean hemoglobin drop and hematocrit changes.
  • Carbetocin may reduce the need for additional uterotonics or antiemetic therapy postoperatively.

Cite This Study

Tarin et al. (2025) studied this question.

synapsesocial.com/papers/68f01110f081da0584b56708https://doi.org/10.54112/bcsrj.v6i7.1881
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Carbetocin vs Oxytocin for Prevention of Postpartum Hemorrhage in Cesarean Delivery: A Systematic Review and Meta-Analysis2025
  2. 2Comparative efficacy of carbetocin versus oxytocin in preventing postpartum hemorrhage during lower segment cesarean section: a prospective randomized controlled trial2025
  3. 3A comparative study on the efficacy of intravenous oxytocin and carbetocin in the prevention and management of postpartum hemorrhage in tertiary care hospital in Uttar Pradesh, India2025
  4. 4Carbetocin in the prevention of postpartum hemorrhage2025
  5. 5Intramyometrial and Intravenous Oxytocin Compared With Intravenous Carbetocin for Prevention of Postpartum Hemorrhage in Elective Cesarean Section: A Quasirandomized Controlled Phase IV Noninferiority Interventional Trial2025 · 1 citations